CONFIDENTIAL LICENSE AGREEMENT Between LABOPHARM EUROPE LIMITED ANGELINI LABOPHARM LP May 20, 2010License Agreement • June 11th, 2010 • Labopharm Inc • Pharmaceutical preparations • England and Wales
In conformity with paragraph 12.2 (3) of National Instrument 51-102 respecting Continuous Disclosure Obligations, Labopharm Inc. has redacted certain provisions of this agreement. Redacted provisions relate to payment terms and other confidential commercial terms.
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF LABOPHARM PHARMACEUTICALS, LLC - among – LABOPHARM PHARMACEUTICALS, LLC - and - LABOPHARM USA, INC. - and - ANGELINI PHARMACEUTICALS, INC. May 20, 2010Limited Liability Company Agreement • June 11th, 2010 • Labopharm Inc • Pharmaceutical preparations • Delaware
AMONG: LABOPHARM PHARMACEUTICALS, LLC, a limited liability company incorporated pursuant to the laws of Delaware with its principal office at 202 Carnegie Center, Suite 204 Princeton, NJ 08540, United States;
LIMITED PARTNERSHIP AGREEMENT - among - LABOPHARM EUROPE LIMITED - and - AMUCHINA S.p.A. - and - ANGELINI LABOPHARM MGP LIMITED - and - ANGELINI LABOPHARM SGP LIMITED May 20, 2010Limited Partnership Agreement • June 11th, 2010 • Labopharm Inc • Pharmaceutical preparations
AMONG: LABOPHARM EUROPE LIMITED, a company incorporated pursuant to the laws of the Republic of Ireland with its registered office at Unit 5 Seapoint Building, 44-45 Clontarf Road, Dublin 3, Ireland;
